NLRP3 and cancer: Furthermore, FMD may reduce the production of ROS caused by ICI treatment in the heart but not cancer cells, and therefore reduce the production of leukotriene and pro-inflammatory factors through the inhibition of NLRP3 pathway by inducing a differential anti-stress response in normal cells32 (Supplementary Fig. 7).